SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-23-000091
Filing Date
2023-11-08
Accepted
2023-11-08 16:08:09
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-20231108.htm   iXBRL 8-K 25533
2 EX-99.1 rna-20231108xexx991.htm EX-99.1 70394
6 gfnzizaxnpmk000001a.jpg GRAPHIC 206622
  Complete submission text file 0001599901-23-000091.txt   484056

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20231108.xsd EX-101.SCH 1931
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20231108_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20231108_pre.xml EX-101.PRE 13067
8 EXTRACTED XBRL INSTANCE DOCUMENT rna-20231108_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 231387861
SIC: 2834 Pharmaceutical Preparations